Toxicity of a modified outpatient regimen of intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in women with newly diagnosed ovarian cancer

被引：0
|
作者：
Ferguson, Sarah E. [1 ]
Black, Destin [1 ]
Chi, Dennis S. [1 ]
Sabbatini, Paul [1 ]
Konner, Jason [1 ]
Tew, William P. [1 ]
Hensley, Martee L. [1 ]
Barakat, Richard R. [1 ]
Aghajanian, Carol [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
GYNECOLOGIC ONCOLOGY | 2007年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S17 / S18
页数：2
相关论文
共 50 条
  • [1] Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer
    Barlin, Joyce N.
    Dao, Fanny
    Zgheib, Nadim Bou
    Ferguson, Sarah E.
    Sabbatini, Paul J.
    Hensley, Martee L.
    Bell-McGuinn, Katherine M.
    Konner, Jason
    Tew, William P.
    Aghajanian, Carol
    Chi, Dennis S.
    GYNECOLOGIC ONCOLOGY, 2012, 125 (03) : 621 - 624
  • [2] A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer
    Cadoo, Karen A.
    Grisham, Rachel N.
    O'Cearbhaill, Roisin E.
    Boucicaut, Nicole N.
    Henson, Melissa
    Iasonos, Alexia
    Zhou, Qin
    Sarasohn, Debra M.
    Gallagher, Jacqueline
    Kravetz, Sara
    Zamarin, Dmitriy
    Makker, Vicky
    Sabbatini, Paul J.
    Tew, William P.
    Aghajanian, Carol
    Konner, Jason A.
    GYNECOLOGIC ONCOLOGY, 2020, 157 (01) : 214 - 221
  • [3] Intraperitoneal cisplatin and paclitaxel in ovarian cancer
    Armstrong, DK
    Bundy, B
    Wenzel, L
    Huang, HQ
    Baergen, R
    Lele, S
    Copeland, LJ
    Walker, JL
    Burger, RA
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01): : 34 - 43
  • [4] Intraperitoneal cisplatin and paclitaxel in ovarian cancer
    Hariprasad, Roopa
    Kumar, Lalit
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2006, 27 (03) : 35 - 38
  • [5] Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin is comparable to results from GOG 172
    Barlin, J.
    Dao, F.
    Zgheib, N. Bou
    Ferguson, S.
    Sabbatini, P.
    Hensley, M.
    Konner, J.
    Tew, W.
    Aghajanian, C.
    Chi, D.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S36 - S37
  • [6] Analysis of progression-free survival, tolerability and toxicity in patients with stage III ovarian, tubal and peritoneal carcinoma treated with an outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin
    Chi, D.
    Dao, F.
    Ferguson, S.
    Sabbatini, P.
    Hensley, M.
    Konner, J.
    Tew, W.
    Bell-McGuinn, K.
    Barakat, R.
    Aghajanian, C.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S123 - S123
  • [7] Intraperitoneal cisplatin therapy in ovarian cancer: Comparison with standard intravenous carboplatin and paclitaxel
    Ozols, Robert F.
    Bookman, Michael A.
    Young, Robert C.
    Du Bois, Andreas
    Pfisterer, Jacobus
    Reuss, Alexander
    GYNECOLOGIC ONCOLOGY, 2006, 103 (01) : 1 - 6
  • [8] A regimen of outpatient intraperitoneal chemotherapy for advanced ovarian cancer
    Berry, E.
    Matthews, K. S.
    Whitworth, J. M.
    Kendrick, J. E.
    Straughn, J. M.
    Alvarez, R. D.
    Singh, D. K.
    Buttin, B. M.
    Lurain, J. R.
    Schink, J. C.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S15 - S15
  • [9] An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer
    Berry, Emily
    Matthews, Kellie S.
    Singh, Diljeet K.
    Buttin, Barbara M.
    Lurain, John R.
    Alvarez, Ronald D.
    Schink, Julian
    GYNECOLOGIC ONCOLOGY, 2009, 113 (01) : 63 - 67
  • [10] Feasibility and Safety of a Modified Outpatient Regimen With Intravenous/Intraperitoneal Chemotherapy for Optimally Debulked Stage III Ovarian Cancer
    Bruixola, Gema
    Domingo, Santiago
    Diaz, Roberto
    Caballero, Javier
    Palomar, Laura
    De La Cueva, Helena
    Santaballa, Ana
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (02) : 214 - 221
12345